Biolegend, 640905, FITC Annexin V, 25tests

Annexin V (or Annexin A5) is a member of the annexin family of intracellular proteins that binds to phosphatidylserine (PS) in a calcium-dependent manner. PS is normally only found on the intracellular leaflet of the plasma membrane in healthy cells, but during early apoptosis, membrane asymmetry is lost and PS translocates to the external leaflet. Fluorochrome-labeled Annexin V can then be used to specifically target and identify apoptotic cells. Annexin V Binding Buffer (cat. no. 422201) is recommended for use with Annexin V staining.Annexin V binding alone cannot differentiate between apoptotic cells and necrotic. Therefore, we recommend using our Helix NP™ Blue (Cat. No. 425305), Helix NP™ Green (Cat.  No. 425303) or Helix NP™ NIR (Cat. No. 425301). Early apoptotic cells will exclude 7-AAD and PI, while late stage apoptotic cells and necrotic cells will stain positively, due to the passage of these dyes into the nucleus where they bind to DNA.
25tests
Verified Reactivity: Human, Mouse, Rat
Reported Reactivity: Other Species
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation: The purified protein was conjugated with FITC under optimal conditions.
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: The Annexin V solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this product is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per 100,000 - million cells in a 100 µl volume of Annexin V Binding Buffer (Cat No. 422201). It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)
Application Notes: Annexin V Staining Wash cells twice with cold BioLegend Cell Staining Buffer (Cat. No. 420201) and then resuspend cells in Annexin V Binding Buffer (Cat. No. 422201) at a concentration of 1x106 cells/mL. Transfer 100 µL of cell suspension in 5 mL test tube. Add 5 µL of fluorochrome conjugated Annexin V. Stain with a viability dye, such as PI (Cat. No. 421301), 7-AAD (Cat. Nos. 420403 & 420404), or Helix NP dyes (Cat. Nos. 425301, 425303, & 425305), if desired. Gently vortex the cells and incubate for 15 min at RT (25°C) in the dark. Add 400* µL of Annexin V Binding Buffer (Cat. No. 422201) to each tube. *For more concentrated samples, add a minimum of 200 µl of Annexin V Binding Buffer in this step. Analyze by flow cytometry. For a better experience detecting apoptosis, we now recommend Apotracker™. Cell staining with Apotracker™ is Calcium independent. Thus, no special buffers are required, and the protocol can be shortened for single-step co-staining with other reagents.
Application References(PubMed link indicates BioLegend citation): Koopman G, et al. 1994. Blood 84:1415. Vermes I, et al. 1995. J. Immunol. Methods 184:39. Dachary-Prigent J, et al. 1993. Blood 81:2554. Sekine C, et al. 2009. Int Immunol. PubMed Grujic M, et al. 2010. J. Immunol. 185:1730. PubMed Mulik RS, et al. 2010. Int J Pharm. 398:190. PubMed Gupta A, et al. 2011. Leuk Res. 35:1498. PubMed Speth C,et al. 2013. J Infect Dis. 207:823. PubMed Wang Q, et al. 2013. Genes Dev. 27:615. PubMed Gill K, et al. 2013. Biocheim Biophys Acta. 830:2763. PubMed Juel HB, et al. 2013. PLoS One. 8:64619. PubMed Hellmann J, et al. 2013. J. Immunol. 191:1383. PubMed Sequier S, et al. 2013. PLoS One. 8:70937. PubMed Galski H, et al. 2013. Biochem Pharmacol. 86:584. PubMed Chen YL, et al. 2013. J Exp Med. PubMed Lin WH, et al. 2014. PLoS One. 9:83160. PubMed Salge-Bartles U, 2014. Thromb res. 133:244. PubMed Zhang X, et al. 2014. Acta Biochim Biophys Sin. 46:261. PubMed Intermann J, et al. 2014. Cell Signal. 26:1567. PubMed de Vires M, 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed M Parrula MC, et al. 2014. Virus Res. 189:206. PubMed Passaro C, et al. 2014. Mol Oncol. 9:78. PubMed Tsou WI, et al. 2014. J Biol Chem. 289:25750. PubMed Awojoodu AO, et al. 2014. Blood. 124:1941. PubMed Xiong R, et al. 2014. Toxicol Appl Pharmacol. 280:285. PubMed Liu J, et al. 2015. J Mol Cell Cardiol. 80:10. PubMed
Product Citations: Derudder E, et al. 2016. Proc Natl Acad Sci U S A. 113: 5065-5070. PubMed Yao Z, et al. 2018. J Virol. 92:00:00. PubMed Uriostegui–Arcos M, et al. 2020. Open Biol. 10:200050. PubMed Gallego-Murillo JS, et al. 2022. Biotechnol Bioeng. 119:3096. PubMed Du X, et al. 2023. Nucleic Acids Res. 51:1050. PubMed Vanoli F, et al. 2023. Oncogenesis. 12:8. PubMed Lei K, et al. 2023. iScience. 26:106001. PubMed Ohuchi K, et al. 2023. Biomed Rep. 18:28. PubMed Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed Perez GI, et al. 2023. Vaccines (Basel). 11:. PubMed Segaliny AI, et al. 2023. Commun Biol. 6:380. PubMed Potez M, et al. 2023. Front Oncol. 13:1124272. PubMed Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed Quintela M, et al. 2023. Clin Epigenetics. 15:63. PubMed Quintela M, et al. 2023. Br J Cancer. . PubMed Zhang T, et al. 2022. EBioMedicine. 77:103872. PubMed Dhoonmoon A, et al. 2022. Nat Commun. 13:5063. PubMed Glynn RA, et al. 2022. J Immunol. 208:371. PubMed Cao H, et al. 2022. Br J Haematol. 198:155. PubMed Ugamraj HS, et al. 2022. MAbs. 14:2095949. PubMed Cao L, et al. 2022. Cell Rep. 40:111156. PubMed Choi UY, et al. 2022. Cell Rep. 40:111234. PubMed Kimmerling RJ, et al. 2022. Commun Biol. 5:1295. PubMed Chen X, et al. 2022. Front Pharmacol. 13:1028692. PubMed Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed Önel T, et al. 2023. Naunyn Schmiedebergs Arch Pharmacol. :. PubMed Papakonstantinou A, et al. 2022. Int J Mol Sci. 24: . PubMed Li J, et al. 2023. J Biol Chem. 299:102875. PubMed Martinelli M, et al. 2023. iScience. 26:105860. PubMed Tay HG, et al. 2023. Mol Ther. 31:825. PubMed Dean BD, et al. 2023. J Immunother Cancer. 11: . PubMed Lieschke E, et al. 2022. Cell Death Differ. 29:1004. PubMed Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed Kim EH, et al. 2020. Elife. 9:00. PubMed Kitayama J, et al. 2016. PLoS One. 11: 0154542. PubMed Gedye C, et al. 2016. Sci Rep. 6: 25220. PubMed Carlsson J, et al. 2015. PLoS One. 10: 0143741. PubMed Bouhaddou M, et al. 2018. PLoS Comput Biol. 14:e1005985. PubMed Espinosa-Cueto P, et al. 2017. PLoS One.. 10.1371/journal.pone.0182126. PubMed Dowling CM, et al. 2021. Sci Adv. 7:. PubMed Lin YN, et al. 2022. Oncoimmunology. 11:2027136. PubMed Gupta A, et al. 2011. Leuk Res. 35:1498. PubMed Fujii T, et al. 2015. Proc Natl Acad Sci U S A. 112: 12800 - 12805. PubMed Cardoso B, et al. 2015. PLoS One. 10: 0143897. PubMed Alcon C, et al. 2020. Cell Death Dis. 0.898611111. PubMed Figueiredo T, et al. 2020. Mol Psychiatry. . PubMed Yamauchi T et al. 2018. Cancer cell. 33(3):386-400 . PubMed Feng W, et al. 2017. Nat Commun. 0.697916667. PubMed Jones PD, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1711. PubMed Lopes-Coelho F, et al. 2021. Front Oncol. 11:656229. PubMed Wang Q, et al. 2022. Nat Commun. 13:3022. PubMed Olelewe C, et al. 2022. iScience. 25:104340. PubMed Ramalingam P, et al. 2020. J Exp Med. 217:00:00. PubMed Bowen ME, et al. 2019. Dev Cell. 50:212. PubMed Sales–Dias J, et al. 2019. PLoS One. 14:e0217002. PubMed Santos LC, et al. 2019. Nat Commun. 1.328472222. PubMed Lim JA, et al. 2018. BMC Cancer. 0.860416667. PubMed Venter C, et al. 2017. Cell Physiol Biochem. 43:1288. PubMed Kim Y, et al. 2020. J Neurochem. 155:177. PubMed Hassan MIA, et al. 2021. Comput Struct Biotechnol J. 19:880. PubMed Soprano M, et al. 2016. PLoS One. 11: 0155970. PubMed Macpherson L, et al. 2020. Nature. 577:266. PubMed Karavasili C, et al. 2017. International Journal of Pharmaceutics. 10.1016/j.ijpharm.2017.05.061. PubMed Thompson PJ et al. 2019. Cell metabolism. 29(5):1045-1060 . PubMed Noguchi F, et al. 2017. Mol Cancer Ther. 1.316666667. PubMed Kumar S, et al. 2018. Cancers (Basel). 0.724305556. PubMed Fortin J, et al. 2020. Cancer Cell. 37:308. PubMed Vereertbrugghen A, et al. 2021. Front Oncol. 11:598319. PubMed Sun V, et al. 2021. Front Immunol. 12:716661. PubMed Coray M, et al. 2022. Int J Mol Sci. 23:. PubMed He C, et al. 2021. Oncoimmunology. 1897295:10. PubMed Pfalzgraff A, et al. 2016. Sci Rep. 6:31577. PubMed O'Neill K, et al. 2016. Genes Dev. 30: 973-988. PubMed Liu J, et al. 2015. J Mol Cell Cardiol. 80:10. PubMed Vries M, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:240. PubMed Chen MS, et al. 2019. Mol Cancer Res. 17:697. PubMed Ni F, et al. 2019. Cell Stem Cell. 24:608. PubMed Ning X, et al. 2019. Mol Cell. 74:19. PubMed Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed Naqvi N,et al. 2017. Sci Rep.. 10.1038/s41598-017-12753-1. PubMed Wang M, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.097. PubMed Beeravolu N, McKee C, Chaudhry G 2017. J App Toxicol. 10.1002/jat.3469. PubMed Kim OV, et al. 2022. iScience. 25:104654. PubMed Shahzadi SK, et al. 2022. Clin Sci (Lond). 136:181. PubMed Kolbrink B, et al. 2022. Biochem J. 479:259. PubMed Parrula M, et al. 2014. Virus Res. 189:206. PubMed Brigger D, et al. 2015. Cell Death Dis. 6: e1861. PubMed Zhang J, et al. 2016. Cell Death Dis. 7:e2266. PubMed Wang D, et al. 2016. J Cell Sci. 129: 2261 - 2272. PubMed Uchtenhagen H, et al. 2016. Nat Commun. 7:12614. PubMed Geiger R, et al. 2016. Cell. 167:829-842. PubMed Esteghamat F, et al. 2019. Nat Genet. 51:1233. PubMed Blümel E, et al. 2020. Oncoimmunology. 9:1751561. PubMed Sekine C, et al. 2009. Int Immunol. 1.079861111. PubMed Kinsella S, et al. 2021. Cell Rep. 37:109789. PubMed O'Connor MJ, et al. 2021. Oncogene. 40:4872. PubMed Madala HR, et al. 2020. Cancer Res. 3492:80. PubMed Clements KE, et al. 2020. Nat Commun. 4.706944444. PubMed Rauzan M, et al. 2017. PLoS One. 12:e0174107. PubMed Liu Y, et al. 2017. Acta Biomater. 10.1016/j.actbio.2017.08.021. PubMed Chiani M, et al. 2017. Artif Cells Nanomed Biotechnol. 10.1080/21691401.2017.1337029. PubMed Yang L, et al. 2021. Cell Death Differ. 28:2616. PubMed Martín Monreal MT, et al. 2021. Front Immunol. 12:716250. PubMed Schmitz RL, et al. 2021. Cells. 10:. PubMed Babaei A, et al. 2021. Adv Pharm Bull. 11:361. PubMed Salge-Bartels U, et al. 2014. Thromb Res. 133:244. PubMed Passaro C, et al. 2014. Mol Oncol. 9:78. PubMed Ligtenberg M, et al. 2016. J Immunol. 196: 759 - 766. PubMed Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed Herold N, et al. 2017. Nat Med. 23:256-263. PubMed Xie S, et al. 2021. Sci Rep. 0.660416667. PubMed Müller I, et al. 2020. Mol Cell. 970:77. PubMed Kamiyama N, et al. 2017. Antiviral Res. 10.1016/j.antiviral.2017.08.007. PubMed Montero–Herradón S, et al. 2017. Organogenesis. 0.675. PubMed Nunes SC, et al. 2018. Sci Rep. 6.939583333. PubMed Sharif T, et al. 2018. Autophagy. 1.101388889. PubMed Eichelmann AK, et al. 2018. Sci Rep. 8:17553. PubMed Blümel E, et al. 2019. Oncoimmunology. 8:e1641387. PubMed Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed Norkin M, et al. 2021. Cell Rep. 35:109026. PubMed Krauss PL, et al. 2021. Front Immunol. 12:730672. PubMed Zhu Y, et al. 2022. Clin Transl Med. 12:e887. PubMed Khatib JB, et al. 2022. Oncotarget. 13:1078. PubMed Yoon Y, et al. 2016. Stem Cell Reports. 7:840-853. PubMed Chheda Z, et al. 2016. J Immunol. 197: 2016 - 2026. PubMed Slone E, et al. 2015. J Leukoc Biol. 98: 791 - 804. PubMed Séguier S, et al. 2013. PLoS One. 8:70937. PubMed Liu H, et al. 2020. Cell Death Dis. 0.767361111. PubMed Zervou S, et al. 2017. PLoS One.. 10.1371/journal.pone.0182994. PubMed Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed Matsuda K, et al. 2021. Cell Rep Methods. 1:100122. PubMed Vanoli F, et al. 2021. Oncogene. 40:5095. PubMed Liu H, et al. 2021. J Immunother Cancer. 9:. PubMed Smith CM, et al. 2021. Biochem J. 478:3331. PubMed Li Y, et al. 2021. Sci Transl Med. 13:. PubMed Meyer N, et al. 2021. J Clin Med. 10:. PubMed Wang Q, et al. 2013. Genes Dev. 27:615. PubMed Douguet L, et al. 2016. PLoS One. 11:e0166164. PubMed Toutounchian J, et al. 2016. Mol Pharmacol. 91(1):1-13. PubMed Pajarillo E, et al. 2020. J Biol Chem. 295:3040. PubMed Litzenburger UM, et al. 2017. Genome Biol. 18:15. PubMed Rajavel T, et al. 2017. Sci Rep. 2.665277778. PubMed Grujic M, et al. 2010. J Immunol. 185:1730. PubMed Gholamrezaei M, et al. 2021. Iran J Parasitol. 15:475. PubMed Meyer N, et al. 2021. Int J Mol Sci. 22:. PubMed Kolbrink B, et al. 2022. Cell Mol Life Sci. 79:387. PubMed Alsina-Sanchis E, et al. 2020. Mol Cancer Res. . PubMed L Chang, Y Li, D Kaplan 2016. Sci Rep. 6:36862. PubMed Becker A, et al. 2016. Sci Rep. 6: 33847. PubMed Kumai T, et al. 2015. Sci Rep. 5:16280. PubMed Polak R, et al. 2015. Blood. 126: 2404 - 2414. PubMed Matsumoto A, et al. 2019. J Extracell Vesicles. 9:1696517. PubMed Pirali T, et al. 2017. ChemMedChem. 1.570833333. PubMed Ishida M, et al. 2021. Int J Mol Sci. 22:. PubMed Lee DH, et al. 2020. Circ Res. 127:1182. PubMed Galski H, et al. 2013. Biochem Pharmacol. 86:584. PubMed Tsou W, et al. 2014. J Biol Chem. 289:25750. PubMed Dhoonmoon A, et al. 2020. Nucleic Acids Res. 48:7252. PubMed Hafez A, et al. 2017. Oncogenesis. 10.1038/oncsis.2017.46. PubMed Putheti P, et al. 2010. PLoS One. 5:e8706. PubMed Nastasi C, et al. 2021. Sci Rep. 11:1458. PubMed Molinar-Inglis O, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed Erdogan M, et al. 2022. Chem Biodivers. 19:e202200659. PubMed Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed Liu B, et al. 2016. J Biol Chem. 291: 23869 - 23881. PubMed Lhuillier C, et al. 2015. J Biol Chem. 290: 16797 - 16811. PubMed Passaro C, et al. 2013. Endocr Relat Cancer. 20:633. PubMed Mulik R, et al. 2010. Int J Pharm. 398:190. PubMed Speth C, et al. 2013. J Infect Dis. 207:823. PubMed Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed Lee HW, et al. 2018. Am J Physiol Renal Physiol. 314:F280. PubMed Ki H, et al. 2017. Biomed Pharmacother. 10.1016/j.biopha.2017.09.118. PubMed Shadboorestan A, et al. 2022. Iran J Basic Med Sci. 25:506. PubMed Huang Y, et al. 2022. Front Cell Dev Biol. 9:837777. PubMed Babaei A, et al. 2020. Daru. 28:555. PubMed King R, et al. 2021. Sci Adv. 7:eabj5293. PubMed Lin W, et al. 2014. PLoS One. 9:83160. PubMed Zhang X, et al. 2014. Acta Biochim Biophys Sin. 46:261. PubMed CO L, et al. 2015. Nat Commun. 6: 7739. PubMed Huang YL, et al. 2020. Elife. 9:00. PubMed Schuler F, et al. 2017. Nat Commun. . 10.1038/s41467-017-01850-4. PubMed Di Somma S, et al. 2019. Cancers (Basel). 1.70625. PubMed Abu El Maaty MA, et al. 2021. Sci Adv. 7: . PubMed Bahl S, et al. 2021. Cell Death Dis. 12:469. PubMed Jackson LM, et al. 2021. Nucleic Acids Res. 49:12855. PubMed Faria M, et al. 2017. PLoS One. 12(2):e0172689. PubMed Jones P, et al. 2016. J Biol Chem. 291: 16318 - 16327. PubMed Awojoodu A, et al. 2014. Blood. 124:1941. PubMed Intemann J, et al. 2014. Cell Signal. 26:1567. PubMed Labi V, et al. 2019. Genes Dev. 33:1673. PubMed Fang P, et al. 2019. Commun Biol. 0.315972222. PubMed Kumar S, et al. 2019. Int J Cancer. 146:1652. PubMed Zhao CC, et al. 2018. Oncol Rep. 40:3392. PubMed Schleicher EM, et al. 2018. Nucleic Acids Res. 46:8908. PubMed Thomas A, et al. 2017. PLoS One.. 10.1371/journal.pone.0183542. PubMed Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed Alcon C, et al. 2021. Cells. 10:. PubMed Cao H, et al. 2021. Nat Commun. 12:1792. PubMed Clements KE, et al. 2018. Nucleic Acids Res. 46:8898. PubMed Bostanabad SY, et al. 2021. Sci Rep. 11:1539. PubMed Monzen S, et al. 2022. Mol Clin Oncol. 16:19. PubMed Konda P, et al. 2022. Am J Cancer Res. 12:210. PubMed Wu J, et al. 2021. Adv Sci (Weinh). 8:e2101029. PubMed Zhang Y, et al. 2021. Cell Death Dis. 0.563194444. PubMed Kang JH, et al. 2020. Cell Death Dis. 0.803472222. PubMed Dewdney B, et al. 2020. Sci Rep. 10:16769. PubMed Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed Coutaz M, et al. 2016. Sci Rep. 6:39117. PubMed Akane K, et al. 2016. Proc Natl Acad Sci U S A. 113: 2460 - 2465. PubMed Xiong R, et al. 2014. Toxicol Appl Pharmacol. 280:285. PubMed Chen Y, et al. 2013. J Exp Med. 210:2515. PubMed Mendès C, et al. 2019. Sci Rep. 9:14107. PubMed Lopes–Coelho F, et al. 2017. Oncotarget. 8:82803. PubMed Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed Thanuthanakhun N, et al. 2017. PLoS One. . 10.1371/journal.pone.0187610. PubMed Kuntz E, et al. 2017. Nat Med. 10.1038/nm.4399. PubMed Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed Bensberg M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed Paparella AS, et al. 2021. Nat Commun. 12:6285. PubMed Huang YL, et al. 2021. iScience. 24:103168. PubMed Bottardi S, et al. 2020. Exp Hematol. 68:88. PubMed Siddhartha V, et al. 2017. Artif Cells Nanomed Biotechnol . 10.1080/21691401.2017.1313267. PubMed He J, et al. 2017. FASEB J. 31:2893. PubMed Lyu X, et al. 2019. BMC Genomics. 1.235416667. PubMed Jing Y, et al. 2019. J Allergy Clin Immunol. 144:1377. PubMed Quan M, et al. 2019. Oncol Rep. 41:3051. PubMed Kasikara C, et al. 2021. J Clin Invest. 131:. PubMed Ning N, et al. 2022. Theranostics. 12:5537. PubMed Du Z, et al. 2020. J Allergy Clin Immunol. . PubMed Pahari S, et al. 2020. Autophagy. 1.375694444. PubMed Schleicher EM, et al. 2020. PLoS Genet. 16:e1009176. PubMed Langsch S, et al. 2016. Cancer Res . 76: 4160 - 4169. PubMed Xiong R, et al. 2015. Mol Pharmacol. 88: 1045 - 1054. PubMed Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed Juel H, et al. 2013. PLoS One. 8:64619. PubMed Gill K, et al. 2013. Biochim Biophys Acta. 1830:2763. PubMed Young MM, et al. 2019. Cell Death Dis. 1.004861111. PubMed Santos I, et al. 2019. Nutrients. 2.210416667. PubMed Vancsik T, et al. 2019. Cancer Med. 3.313888889. PubMed Zheng M, et al. 2019. Proc Natl Acad Sci U S A. 116:12422. PubMed Zheng Q, et al. 2017. Mol Oncol. 10.1002/1878-0261.12056. PubMed Wang Y, et al. 2022. Front Cardiovasc Med. 9:876087. PubMed Shankman LS, et al. 2021. Curr Biol. 31:2469. PubMed
RRID: AB_2561291 (BioLegend Cat. No. 640905) AB_2561292 (BioLegend Cat. No. 640906) AB_2629519 (BioLegend Cat. No. 640945)
Biology Area: Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience
Gene ID: 308
UniProt: View information about Annexin V on UniProt.org
Regulatory Status: RUO
Other Names: Annexin A5, Dead, Apoptosis
Q: How is your Annexin made and what sequence does it cover?
A: It is made in E. coli, covering human aa Met1-Asp320.
Q: How does pH and staining temperature affect Annexin V-Phosphatidylserine binding?
A: Annexin-Phosphatidylserine binding is lost below pH 5.2 and with prolonged incubation over a temperature of 42°C.
Q: Why do I need to use Annexin V Binding Buffer?
A: Annexin V binding requires the presence of calcium in the solution.  So, we provide Annexin V Binding Buffer (cat # 422201), which is optimized for the best performance of Annexin V staining.
Q: Can I use RPMI during Annexin V staining?
A: It is best to follow protocol as described on the product data sheet. Moreover, RPMI 1640 has a relatively high concentration of phosphate and low calcium ion concentration, which negatively impacts Annexin binding to its target phosphatidylserine (PS). Measurement of cell death by using Annexin V may also be significantly affected by time of incubation on ice, calcium concentration, and type of medium.
Q: Can I freeze Annexin V conjugates?
A: It should not be frozen as it will lead to loss of biological activity due to dimerization.
Q: Is Annexin V suitable for conjugation with the Maxpar® kit for CyTOF®?
A: Maxpar® Labeling kits require the protein to be partially reduced, so the metal chelate can be introduced through an SH group in the hinge region of the reduced antibody. Human Annexin V contains only one Cysteine which was reported to be chemically inactive. Thus, the Maxpar® labeling protocol would not work with Annexin V, unless a free –SH group can be introduced to Annexin V.  For more information regarding SH-mediated conjugation of Annexin V please consult published papers such as this one.